Profile image
Story Views

Last Hour:
Last 24 Hours:

Global Leukemia Therapeutics Market 2016-2021 drivers and restraints

Friday, October 21, 2016 2:22
% of readers think this story is Fact. Add your two cents.

According to the report “Leukemia Therapeutics Market” by disease condition, by diagnosis,by treatment, by drugs and by Region – Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021), published by Market Data Forecast, the global market is projected to reach USD 8.82 Billion by 2021, at a CAGR of 9.5% from 2016 to 2021.

For full report refer to

Leukemia is the type of blood cancer and the ninth most common one in males. It accounts for almost 0.0148% of all the men and 0.009% of all the women worldwide. It is a type of blood cancer resulting in the abnormal production of blood cells, generally leukocytes. Leukemia cases are more common in adults and are observed to progress with aging.

Free sample for the report is available at

Rising prevalence of leukemia, funding to increase disease awareness, and increasing consumer awareness regarding leukemia treatments and drugs are the main factors that are driving the market growth. Government support and enhanced healthcare infrastructure are providing opportunities for the manufacturers to penetrate into this market.

Request customization at

Global market for Leukemia Therapeutics is segmented based on Type and Product into further sub-segments as follows:

By disease condition
•Chronic lymphatic leukemia
•Acute lymphatic leukemia
•Chronic myeloid leukemia
•Acute myeloid leukemia

By diagnosis
•CT scan

By treatments
•Radiation therapy
•Targeted therapy
•Bone marrow transplant
•Stem cell therapy

By drugs

Geographically, the market for Leukemia Therapeutics market is segmented as below:
•North America
•Latin America
•Middle-East and Africa

Enquire more about the report at

F. Hoffmann-La Roche Ltd , GlaxoSmithKline Pharmaceuticals Limited , Novartis International AG, Bristol-Myers Squibb , Eisai Co. Ltd, Biogen Idec , ERYtech Pharma , Celgene Corporation, Genmab A/S, Cephalon Inc., Clavis Pharma, and Pfizer Inc. are the major players of Global Leukemia Therapeutics market.

Buy now

About us:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.

Market Data Forecast, Inc.
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)

We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.